{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T16:31:44Z","timestamp":1724862704316},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,9,20]],"date-time":"2011-09-20T00:00:00Z","timestamp":1316476800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s12348-011-0036-8","type":"journal-article","created":{"date-parts":[[2011,9,19]],"date-time":"2011-09-19T10:19:05Z","timestamp":1316427545000},"page":"147-155","source":"Crossref","is-referenced-by-count":5,"title":["Phase II placebo-controlled study of nepafenac ophthalmic suspension 0.1% for postoperative inflammation and ocular pain associated with cataract surgery in Japanese patients"],"prefix":"10.1186","volume":"1","author":[{"given":"Jiro","family":"Numaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,20]]},"reference":[{"key":"36_CR1","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/j.jcrs.2007.05.015","volume":"33","author":"T Walters","year":"2007","unstructured":"Walters T, Raizman M, Ernest P, Gayton J, Lehmann R (2007) In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac. J Cataract Refract Surg 33:1539\u20131545","journal-title":"J Cataract Refract Surg"},{"key":"36_CR2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1023\/A:1007049015148","volume":"24","author":"DA Gamache","year":"2000","unstructured":"Gamache DA, Graff G, Brady MT, Spellman JM, Yanni JM (2000) Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy. Inflammation 24:357\u2013370","journal-title":"Inflammation"},{"key":"36_CR3","first-page":"45","volume-title":"Phacoemulsification and aspiration of cataract: surgical techniques, complications, and results","author":"JM Emery","year":"1979","unstructured":"Emery JM, Little JH (1979) Phacoemulsification and aspiration of cataract: surgical techniques, complications, and results. Mosby, St Louis, pp 45\u201348"},{"key":"36_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jcrs.2006.08.043","volume":"33","author":"SS Lane","year":"2007","unstructured":"Lane SS, Modi SS, Lehmann RP, Holland EJ (2007) Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery. J Cataract Refract Surgery 33:53\u201358","journal-title":"J Cataract Refract Surgery"},{"key":"36_CR5","first-page":"527","volume":"1","author":"M Nardi","year":"2007","unstructured":"Nardi M, Lobo C, Bereczki A, Cano J, Zagato E, Potts S, Sullins G, Notivol R, for the International C-04\u201365 Study Group (2007) Analgesic and anti-inflammatory effectiveness of nepafenac 0.1% for cataract surgery. Clin Ophthalmol 1:527\u2013533","journal-title":"Clin Ophthalmol"},{"key":"36_CR6","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1089\/jop.2008.0023","volume":"24","author":"WA Maxwell","year":"2008","unstructured":"Maxwell WA, Reiser HJ, Stewart RH, Cavanagh HD, Walters TR, Sager DP, Meuse PA, the Nepafenac Study Group (2008) Nepafenac dosing frequency for ocular pain and inflammation associated with cataract surgery. J Ocul Pharmacol Ther 24:593\u2013599","journal-title":"J Ocul Pharmacol Ther"},{"key":"36_CR7","first-page":"223","volume":"48","author":"MS Reddy","year":"2000","unstructured":"Reddy MS, Suneetha N, Thomas RK, Battu RR (2000) Topical diclofenac sodium for treatment of postoperative inflammation in cataract surgery. Indian J Ophthalmol 48:223\u2013226","journal-title":"Indian J Ophthalmol"},{"key":"36_CR8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3928\/1542-8877-19980701-03","volume":"29","author":"SM el-Harazi","year":"1998","unstructured":"el-Harazi SM, Ruiz RS, Feldman RM, Villanueva G, Chuang AZ (1998) A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells. Ophthalmic Surg Lasers 29:539\u2013544","journal-title":"Ophthalmic Surg Lasers"},{"key":"36_CR9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/112067219700700306","volume":"7","author":"TA Demco","year":"1997","unstructured":"Demco TA, Sutton H, Demco CJ, Raj PS (1997) Topical diclofenac sodium compared with prednisolone acetate after phacoemulsification-lens implant surgery. Eur J Ophthalmol 7:236\u2013240","journal-title":"Eur J Ophthalmol"},{"key":"36_CR10","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.ophtha.2006.12.029","volume":"114","author":"ED Donnenfeld","year":"2007","unstructured":"Donnenfeld ED, Holland EJ, Sewart RH, Gow JA, Grillone LR, Bromfenac Ophthalmic Solution 0.09%(Xibrom) Study group (2007) Bromfenac ophthalmic solution 0.09%(Xibrom) for postoperative ocular pain and inflammation. Ophthalmology 114:1653\u20131662","journal-title":"Ophthalmology"},{"key":"36_CR11","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1034\/j.1600-0420.2000.078004421.x","volume":"78","author":"CP Herbort","year":"2000","unstructured":"Herbort CP, Jauch A, Othenin-Girard P, Tritten JJ, Fsadni M (2000) Diclofenac drops to treat inflammation after cataract surgery. Acta Ophthalmol Scand 78:421\u2013424","journal-title":"Acta Ophthalmol Scand"},{"key":"36_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0886-3350(13)80036-3","volume":"20","author":"P Othenin-Girard","year":"1994","unstructured":"Othenin-Girard P, Tritten JJ, Pittet N, Herbort CP (1994) Dexamethasone versus diclofenac sodium eyedrops to treat inflammation after cataract surgery. J Cataract Refract Surg 20:9\u201312","journal-title":"J Cataract Refract Surg"},{"key":"36_CR13","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1136\/bjo.64.5.324","volume":"64","author":"K Miyake","year":"1980","unstructured":"Miyake K, Sakamura S, Miura H (1980) Long-term follow up study on the prevention of aphakic cystoid macular edema by topical indomethacin. Br J Ophthalmol 64:324\u2013328","journal-title":"Br J Ophthalmol"},{"issue":"Suppl 1","key":"36_CR14","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/S0886-3350(96)80164-7","volume":"22","author":"L Rossetti","year":"1996","unstructured":"Rossetti L, Bujtar E, Castoldi D, Torrazza C, Orzalesi N (1996) Effectiveness of diclofenac eyedrops in reducing inflammation and the incidence of cystoid macular edema after cataract surgery. J Cataract Refract Surg 22(Suppl 1):794\u2013799","journal-title":"J Cataract Refract Surg"},{"key":"36_CR15","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/S0161-6420(90)32423-5","volume":"97","author":"AJ Flach","year":"1990","unstructured":"Flach AJ, Stegman RC, Graham J, Kruger LP (1990) Prophylaxis of aphakic cystoid macular edema without corticosteroids, a paired-comparison, placebo-controlled double-masked study. Ophthalmology 97:1253\u20131258","journal-title":"Ophthalmology"},{"key":"36_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0021-5155(99)00176-8","volume":"44","author":"K Miyake","year":"2000","unstructured":"Miyake K, Masuda K, Shirato S, Oshika T, Eguchi K, Hoshi H, Majima Y, Kimura W, Hayashi F (2000) Comparison of diclofenac and fluorometholone in preventing cystoid macular edema after small incision cataract surgery: a multicentered prospective trial. Jpn J Ophthalmol 44:58\u201367","journal-title":"Jpn J Ophthalmol"},{"key":"36_CR17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1023\/A:1007001131987","volume":"24","author":"T-L Ke","year":"2000","unstructured":"Ke T-L, Graff G, Spellman JM, Yanni JM (2000) Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In vitro bioactivation and permeation of external ocular barriers. Inflammation 24:371\u2013384","journal-title":"Inflammation"},{"key":"36_CR18","first-page":"132","volume":"32","author":"M Sawa","year":"1988","unstructured":"Sawa M, Tsurimaki Y, Tsuru T, Shimizu H (1988) New quantitative method to determine protein concentration and cell numbr in aqueous in vivo. Jpn J Ophthalmol 32:132\u2013142","journal-title":"Jpn J Ophthalmol"},{"key":"36_CR19","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/S0886-3350(13)80071-5","volume":"18","author":"T Oshika","year":"1992","unstructured":"Oshika T, Yoshimura K, Miyata N (1992) Postsurgical inflammation after phacoemulsification and extracapsular ectraction with soft or conventional intraocular lens implantaion. J Cataract Refract Surg 18:356\u2013361","journal-title":"J Cataract Refract Surg"},{"key":"36_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/bjo.78.2.91","volume":"78","author":"SM Shah","year":"1994","unstructured":"Shah SM, Spalton DJ (1994) Changes in anterior chamber flare and cell following cataract surgery. Br J Ophthalmol 78:91\u201394","journal-title":"Br J Ophthalmol"},{"key":"36_CR21","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/S0161-6420(00)00538-8","volume":"108","author":"AC Guidera","year":"2001","unstructured":"Guidera AC, Luchs JI, Udell IJ (2001) Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs. Ophthalmology 108:936\u2013944","journal-title":"Ophthalmology"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12348-011-0036-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12348-011-0036-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s12348-011-0036-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12348-011-0036-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,5]],"date-time":"2021-12-05T14:53:05Z","timestamp":1638715985000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12348-011-0036-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,20]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["36"],"URL":"https:\/\/doi.org\/10.1007\/s12348-011-0036-8","relation":{},"ISSN":["1869-5760"],"issn-type":[{"value":"1869-5760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,20]]}}}